Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis

被引:47
|
作者
Habers, G. Esther A. [1 ]
Huber, Adam M. [2 ,3 ]
Mamyrova, Gulnara [4 ]
Targoff, Ira N. [5 ,6 ]
O'Hanlon, Terrance P. [7 ]
Adams, Sharon [8 ]
Pandey, Janardan P. [9 ]
Boonacker, Chantal [1 ]
van Brussel, Marco [1 ]
Miller, Frederick W. [7 ]
van Royen-Kerkhof, Annet [1 ]
Rider, Lisa G. [7 ]
机构
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] IWK Hlth Ctr, Halifax, NS, Canada
[3] Dalhousie Univ, Halifax, NS, Canada
[4] George Washington Univ, Sch Med, Washington, DC USA
[5] Univ Oklahoma, Hlth Sci Ctr, VAMC, Oklahoma City, OK USA
[6] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA
[7] NIEHS, NIH, Bethesda, MD USA
[8] NIH, Ctr Clin, Bethesda, MD 20892 USA
[9] Med Univ S Carolina, Charleston, SC USA
关键词
IDIOPATHIC INFLAMMATORY MYOPATHIES; PROGNOSTIC-FACTORS; GENE POLYMORPHISMS; SYMPTOM ONSET; DERMATOMYOSITIS; PHENOTYPES; CHILDREN; DURATION; POLYMYOSITIS; MULTICENTER;
D O I
10.1002/art.39466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify early factors associated with disease course in patients with juvenile idiopathic inflammatory myopathies (IIMs). Methods. Univariable and multivariable multinomial logistic regression analyses were performed in a large juvenile IIM registry (n = 365) and included demographic characteristics, early clinical features, serum muscle enzyme levels, myositis autoantibodies, environmental exposures, and immunogenetic polymorphisms. Results. Multivariable associations with chronic or polycyclic courses compared to a monocyclic course included myositis-specific autoantibodies (multinomial odds ratio [OR] 4.2 and 2.8, respectively), myositis-associated autoantibodies (multinomial OR 4.8 and 3.5), and a documented infection within 6 months of illness onset (multinomial OR 2.5 and 4.7). A higher overall clinical symptom score at diagnosis was associated with chronic or monocyclic courses compared to a polycyclic course. Furthermore, severe illness onset was associated with a chronic course compared to monocyclic or polycyclic courses (multinomial OR 2.1 and 2.6, respectively), while anti-p155/140 autoantibodies were associated with chronic or polycyclic courses compared to a monocyclic course (multinomial OR 3.9 and 2.3, respectively). Additional univariable associations of a chronic course compared to a monocyclic course included photosensitivity, V-sign or shawl sign rashes, and cuticular overgrowth (OR 2.2-3.2). The mean ultraviolet index and highest ultraviolet index in the month before diagnosis were associated with a chronic course compared to a polycyclic course in boys (OR 1.5 and 1.3), while residing in the Northwest was less frequently associated with a chronic course (OR 0.2). Conclusion. Our findings indicate that myositis autoantibodies, in particular anti-p155/140, and a number of early clinical features and environmental exposures are associated with a chronic course in patients with juvenile IIM. These findings suggest that early factors, which are associated with poorer outcomes in juvenile IIM, can be identified.
引用
收藏
页码:761 / 768
页数:8
相关论文
共 50 条
  • [1] Myositis-associated Autoantibodies in Juvenile Myositis Are Associated with Severe Disease Features and Mortality
    Sherman, Matthew
    Farhad, Payam Noroozi
    Pak, Katherine
    Pinal-Fernandez, Iago
    Sarkar, Kakali
    Neely, Megan
    Targoff, Ira
    Miller, Frederick
    Mammen, Andrew
    Rider, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3216 - 3218
  • [2] ANTI-FHL1 AUTOANTIBODIES IN JUVENILE MYOSITIS ARE ASSOCIATED WITH MYOSITIS-ASSOCIATED AUTOANTIBODIES BUT NOT DISTINCTIVE CLINICAL FEATURES
    Sherman, Matthew A.
    Graf, Rose
    Galindo-Feria, Angeles S.
    Sabbagh, Sara E.
    Pinal-Fernandez, Iago
    Pak, Katherine
    Kishi, Takayuki
    Targoff, Ira N.
    Miller, Fred-Erick W.
    Lundberg, Ingrid E.
    Rider, Lisa G.
    Mammen, Andrew L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 480 - 481
  • [3] Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis
    Pinal-Fernandez, Iago
    Pak, Katherine
    Gil-Vila, Albert
    Baucells, Andres
    Plotz, Benjamin
    Casal-Dominguez, Maria
    Derfoul, Assia
    Martinez-Carretero, Maria Angeles
    Selva-O'Callaghan, Albert
    Sabbagh, Sara
    Casciola-Rosen, Livia
    Albayda, Jemima
    Paik, Julie
    Tiniakou, Eleni
    Danoff, Sonye K.
    Lloyd, Thomas E.
    Miller, Frederick W.
    Rider, Lisa G.
    Christopher-Stine, Lisa
    Mammen, Andrew L.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (02) : 358 - 364
  • [4] Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis
    Pinal-Fernandez, Iago
    Pak, Katherine
    Gil-Vila, Albert
    Baucells, Andres
    Plotz, Benjamin
    Casal-Dominguez, Maria
    Derfoul, Assia
    Angeles Martinez, Maria
    Selva-O'Callaghan, Albert
    Sabbagh, Sara
    Miller, Frederick W.
    Rider, Lisa G.
    Christopher-Stine, Lisa
    Mammen, Andrew
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
    Betteridge, Zoe E.
    Gunawardena, Harsha
    McHugh, Neil J.
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (02)
  • [6] Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
    Zoe E Betteridge
    Harsha Gunawardena
    Neil J McHugh
    Arthritis Research & Therapy, 13
  • [7] Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality
    Sherman, Matthew A.
    Farhadi, Payam Noroozi
    Pak, Katherine
    Trieu, Edward P.
    Sarkar, Kakali
    Targoff, Ira N.
    Neely, Megan L.
    Mammen, Andrew L.
    Rider, Lisa G.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (06) : 963 - 972
  • [8] Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes
    Ramanan, AV
    Feldman, BM
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (04) : 833 - +
  • [9] The Clinical Features of Myositis-Associated Autoantibodies: a Review
    Gunawardena, Harsha
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 52 (01) : 45 - 57
  • [10] The Clinical Features of Myositis-Associated Autoantibodies: a Review
    Harsha Gunawardena
    Clinical Reviews in Allergy & Immunology, 2017, 52 : 45 - 57